Proteinuria Management in Non-Diabetic, Non-Hypertensive Patients

Initial Assessment and Quantification

The initial workup for proteinuria in non-diabetic, non-hypertensive patients should include quantification of proteinuria, comprehensive laboratory evaluation, and renal ultrasound, followed by treatment with ACE inhibitors or ARBs if proteinuria exceeds 0.5 g/day, as recommended by the American College of Physicians 1
Quantify proteinuria using spot urine protein-to-creatinine ratio when dipstick shows ≥1+ protein (roughly correlates to 30 mg/dL or protein-to-creatinine ratio ≥1300 mg/g) 1
Obtain a thorough evaluation to exclude secondary causes of proteinuria, according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines 2

Perform renal ultrasound to assess kidney size, presence of stones, and extrarenal/intrarenal lesions (small kidneys <9 cm may indicate advanced disease) 1
Consider genetic testing only in cases with early onset or positive family history (not routinely recommended) 2

For proteinuria >1 g/day, start ACE inhibitor or ARB treatment with uptitration depending on blood pressure response, as recommended by the National Kidney Foundation 3, 1
Titrate ACE inhibitor or ARB upward as far as tolerated to achieve proteinuria <1 g/day, according to the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) guidelines 3, 4

Restrict dietary sodium to <2.0 g/d (<90 mmol/d) to reduce proteinuria, as recommended by the American Heart Association 3, 6
Normalize weight through appropriate diet and exercise to reduce proteinuria, according to the Academy of Nutrition and Dietetics 6

Monitor labs frequently when on ACE inhibitor or ARB therapy, including serum creatinine, potassium levels, and proteinuria levels, as recommended by the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines 3, 4
Counsel patients to hold ACE inhibitor/ARB and diuretics when at risk for volume depletion (illness, diarrhea, etc.) to prevent acute kidney injury, according to the National Kidney Foundation 3, 7

For diuretic-resistant edema in nephrotic syndrome, consider combination therapy with loop diuretics and thiazide diuretics, as recommended by the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) guidelines 5
For refractory cases, consider mineralocorticoid receptor antagonists (monitor for hyperkalemia) or combination therapy with ACE inhibitor and ARB in young adults without comorbidities, according to the American College of Cardiology 6, 3

Do not stop ACE inhibitor or ARB with modest and stable increase in serum creatinine (up to 30%) unless kidney function continues to worsen or if refractory hyperkalemia develops, as recommended by the National Kidney Foundation 3
Consider kidney biopsy when initial workup is inconclusive, especially with persistent proteinuria >1 g/day despite conservative management, according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines 2